Is ESSA Pharma Inc. (EPIX) a Buy, Sell, or Hold?
ESSA Pharma Inc.
NASDAQ:EPIX
$0.2012 USD
$0.0 (-1.85%)
- Volume
- 5.95M
- Average Volume
- 6.75M
- Market Capitalization
- $9.52M
- P/E Ratio
- -0.87
- Dividend Yield
- 0.00%
- Price Target
- $9.50
- Year High
- $6.45
- Year Low
- $0.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $69.07
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | David Ross Parkinson |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | EPIX |
| CUSIP | 29668H708 |
| CIK | 0001633932 |
| Web | https://www.essapharma.com |
| Phone | 17783310962 |
| Currency | USD |
| Employees | 35 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 69.07 |
| Quick Ratio | 69.07 |
| Cash Ratio | 53.72 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 0.00 |
| Cash Flow | -0.25 |
| Price / Cash Flow | -0.86 |
| Price / Book | 0.08 |
Price Target and Rating
| Average Stock Price Forecast | $9.50 |
| High Stock Price Forecast | $17.00 |
| Low Stock Price Forecast | $2.00 |
| Forecast Upside/Downside | -97.88% |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 5 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.64 |
| Trailing P/E Ratio | -0.87 |
| PEG Ratio | -0.11 |
| P/E Growth | -0.11 |
| Net Income | $-28.54M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | -9.33% |
| Return on Assets | -9.39% |
Financials Score
| AltmanZ Score | 1.05 |
| Piotroski Score | 3.00 |
| Working Capital | 108.9M |
| Total Assets | 110.5M |
| Ebit | -27.64M |
| Market Cap | 9.52M |
| Total Liabilities | 1.6M |
Poll Results
About ESSA Pharma Inc. (NASDAQ:EPIX) Stock
ESSA Pharma Inc. (EPIX) functions as a clinical-stage pharmaceutical firm, concentrating its efforts on developing innovative and exclusive therapies designed to combat prostate cancer. The company's primary drug candidate is EPI-7386, an oral treatment presently undergoing Phase I clinical trials. This investigational compound is intended for individuals suffering from metastatic castration-resistant prostate cancer. Furthermore, ESSA Pharma has established collaborative partnerships with organizations including Caris Life Sciences, Inc., Bayer Consumer Care AG, Janssen Research & Development, LLC, and Astellas Pharma Inc. Founded in 2009, the company's corporate offices are located in Vancouver, Canada. ...
Frequently Asked Questions
-
What is the current ESSA Pharma Inc. (EPIX) stock price?
-
ESSA Pharma Inc.(NASDAQ:EPIX) stock price is $0.2012 in the last trading session. During the trading session, EPIX stock reached the peak price of $6.45 while $0.18 was the lowest point it dropped to. The percentage change in EPIX stock occurred in the recent session was --1.85% while the dollar amount for the price change in EPIX stock was -$-0.0.
-
EPIX's industry and sector of operation?
-
The NASDAQ listed EPIX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of EPIX?
-
Peter A. Virsik | Executive Vice President & Chief Operating Officer
Alessandra Cesano | Chief Medical Officer & Executive Vice President
David Ross Parkinson | President, Chief Executive Officer & Director
Erin Rudsinski | Executive
Neil Thapar | Executive -
How many employees does EPIX have?
-
Number of EPIX employees currently stands at 35. EPIX operates from 999 West Broadway, Vancouver, BC V5Z 1K5, CA.
-
Link for EPIX official website?
-
Official Website of EPIX is: https://www.essapharma.com
-
How do I contact EPIX?
-
EPIX could be contacted at phone #17783310962 and can also be accessed through its website. EPIX operates from 999 West Broadway, Vancouver, BC V5Z 1K5, CA.
-
How many shares of EPIX are traded daily?
-
The average number of EPIX shares traded daily for last 3 months was 6.75M.
-
What is the market cap of EPIX currently?
-
The market value of EPIX currently stands at $9.52M with its latest stock price at $0.2012